# OptimizeRx Corp: Form DEF 14A, filed Apr 29, 2024

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 12:35 ET
- Period: 2024-06-05
- Accession: 0001213900-24-036855
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024036855/ea0204731-01.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390024036855/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390024036855/ea0204731-01.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-036855. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.